New prediction, INNV never gets the original ANDA fluticare approval. Dr.Damage continues to dilute. Vessle sales drop. Dr.Damage still collects a high interest/profit on his INNV loan sharking. INNV sales drop. Many INNV products are dropped. It costs INNV more money to sell their products than they make back in profits. Things will get so bad, we'll wish their was an r/s. INNV goes out of business in 2017 or 2018. We (I) will lose every penny "invested" in INNV. FYI, GSK and Bayer are not interested in a nutracuticle, non-profitable and bankrupt company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.